SectorPharmaceutical
Established Date17/03/2011
Listing Date07/05/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees34
Fiscal Year Ends31/12
Security TypeCommon stock
Office address195 Church Street, 16th Floor, New Haven, Connecticut 06510
Business
IntroductionTrevi Therapeutics, Inc., was incorporated under the laws of the State of Delaware on March 17, 2011. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio, an oral sustained-release nalbuphine formulation for the treatment of chronic cough associated with idiopathic pulmonary fibrosis, other interstitial lung diseases and refractory chronic cough. It retains the global commercial rights to the research therapy.
